窪田製薬ホールディングス(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4596/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2018/10/05 | 日証協 | 398,974株 | -0.23% | 3,503株 | +600.6% | 429,191株 | +1.49% | 11,607株 | +955.18% |
| 2018/09/28 | 日証協 | 399,874株 | -0.45% | 500株 | -93.3% | 422,884株 | -0.82% | 1,100株 | -85.53% |
| 2018/09/21 | 日証協 | 401,674株 | +1.34% | 7,465株 | -68.01% | 426,384株 | +0.4% | 7,600株 | +68.63% |
| 2018/09/14 | 日証協 | 396,374株 | +0.94% | 23,339株 | -17.15% | 424,684株 | +1.29% | 4,507株 | -88.85% |
| 2018/09/07 | 日証協 | 392,674株 | +2.31% | 28,169株 | -49.83% | 419,273株 | +10.32% | 40,406株 | +284.82% |
| 2018/08/31 | 日証協 | 383,809株 | +9.03% | 56,148株 | -2.48% | 380,067株 | -0.47% | 10,500株 | +27.58% |
| 2018/08/24 | 日証協 | 352,009株 | +0.04% | 57,574株 | +6057.65% | 381,864株 | -4.42% | 8,230株 | +82.89% |
| 2018/08/17 | 日証協 | 351,874株 | +1.97% | 935株 | -88.31% | 399,534株 | +2.91% | 4,500株 | -58.41% |
| 2018/08/10 | 日証協 | 345,074株 | -10.46% | 8,000株 | -73.77% | 388,234株 | -4.05% | 10,820株 | -12.74% |
| 2018/08/03 | 日証協 | 385,374株 | +1.38% | 30,500株 | +824.24% | 404,614株 | +1.02% | 12,400株 | +300% |
| 2018/07/27 | 日証協 | 380,139株 | -0.92% | 3,300株 | -75.91% | 400,516株 | +1.29% | 3,100株 | -34.14% |
| 2018/07/20 | 日証協 | 383,674株 | 0% | 13,700株 | 0% | 395,416株 | 0% | 4,707株 | 0% |
| 2018/07/13 | 日証協 | 383,174株 | -1.39% | 15,500株 | -92.72% | 395,209株 | -0.8% | 13,520株 | -34.58% |
| 2018/07/06 | 日証協 | 388,574株 | +7.65% | 212,900株 | +329.46% | 398,389株 | +13.5% | 20,667株 | -64.01% |
| 2018/06/29 | 日証協 | 360,974株 | +7.41% | 49,574株 | -1.64% | 350,992株 | +5.49% | 57,420株 | -1.21% |
| 2018/06/22 | 日証協 | 336,074株 | +9.27% | 50,400株 | -49.95% | 332,722株 | -5.32% | 58,121株 | +24.1% |
| 2018/06/15 | 日証協 | 307,574株 | +3.43% | 100,700株 | +276.11% | 351,401株 | +4.14% | 46,835株 | +441.76% |
| 2018/06/08 | 日証協 | 297,374株 | -9.85% | 26,774株 | -0.37% | 337,446株 | -3.67% | 8,645株 | +15.01% |
| 2018/06/01 | 日証協 | 329,874株 | +3.45% | 26,874株 | -64.81% | 350,301株 | +3% | 7,517株 | -78.51% |
※株式分割は考慮していませんのでご注意ください。
Page Top